N-[(2S)-1-[[(E)-3-amino-2-(2,3-dihydropyridin-6-yl)prop-2-enylidene]amino]propan-2-yl]-N-ethylbutan-1-amine
C17H30N4 — CID 170977725
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2S)-1-[[(E)-3-amino-2-(2,3-dihydropyridin-6-yl)prop-2-enylidene]amino]propan-2-yl]-N-ethylbutan-1-amine
N-[(2S)-1-[[(E)-3-amino-2-(2,3-dihydropyridin-6-yl)prop-2-enylidene]amino]propan-2-yl]-N-ethylbutan-1-amine (PubChem CID 170977725) has the molecular formula C17H30N4 and a molecular weight of 290.45 g/mol. Its IUPAC name is N-[(2S)-1-[[(E)-3-amino-2-(2,3-dihydropyridin-6-yl)prop-2-enylidene]amino]propan-2-yl]-N-ethylbutan-1-amine.
Molecular Properties
| Compound Name | N-[(2S)-1-[[(E)-3-amino-2-(2,3-dihydropyridin-6-yl)prop-2-enylidene]amino]propan-2-yl]-N-ethylbutan-1-amine |
|---|---|
| PubChem CID | 170977725 |
| Molecular Formula | C17H30N4 |
| Molecular Weight | 290.45 g/mol |
| Exact Mass | 290.25 |
| IUPAC Name | N-[(2S)-1-[[(E)-3-amino-2-(2,3-dihydropyridin-6-yl)prop-2-enylidene]amino]propan-2-yl]-N-ethylbutan-1-amine |
| SMILES | CCCCN(CC)[C@@H](C)C/N=C/C(=C\N)C1=NCCC=C1 |
| InChI | InChI=1S/C17H30N4/c1-4-6-11-21(5-2)15(3)13-19-14-16(12-18)17-9-7-8-10-20-17/h7,9,12,14-15H,4-6,8,10-11,13,18H2,1-3H3/b16-12+,19-14+/t15-/m0/s1 |
| InChIKey | MBSWBQXJJXMIHG-TWFCBERLSA-N |
| XLogP | 2.81 |
| TPSA | 53.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 290.45 |
| LogP ≤ 5 | 2.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170977725 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.